HMGCS1 Antibody (Rabbit mAb) [D13C18]

CatNo: F5434

    Application: Reactivity:
    • Lane 1: DLD-1, Lane 2: LNCaP, Lane 3: PC-3, Lane 4: C2C12
    1/

    当該製品は品切れ状态で、メールアドレスをご教示いただければ、お客様に返信いたします。

    代表番号: 045-509-1970|電子メール:sales@selleck.co.jp

    使用情報

    Dilution
    1:1000-1:200000
    1:30
    1:100
    Application
    WB, IP, IHC
    Source
    Rabbit Monoclonal Antibody
    Reactivity
    Human, Mouse, Rat
    Storage Buffer
    PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3
    Storage (from the date of receipt)
    -20°C (avoid freeze-thaw cycles), 2 years
    Predicted MW Observed MW
    57 kDa 57 kDa,36 kDa
    *なぜ予測分子量と実際の分子量が異なるのか?
    下記の原因により、実際の分子量が予測と異なる:タンパク質の翻訳後修飾(リン酸化/糖鎖付加),スプライシングバリアント,イソフォーム,相対的な電荷,ポリマー。
    ポジティブコントロール Human liver cancer tissue; Human liver tissue; Human stomach tissue; Human colon tissue; Mouse colon tissue; Mouse liver tissue; Mouse stomach tissue; Mouse testis tissue; Rat colon tissue; Rat stomach tissue; DLD-1 cells; LNCaP cells; PC-3 cells; C2C12 cells
    ネガティブコントロール Rat skeletal muscle tissue; Mouse skeletal muscle tissue; Human skeletal muscle tissue; Human liver tissue

    プロトコール

    WB
    Experimental Protocol:
     
    Sample preparation
    1. Tissue: Lyse the tissue sample by adding an appropriate volume of ice-cold RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail),and homogenize the tissue at a low temperature or lyse it by sonication on ice, then incubate on ice for 30 minutes.
    2. Adherent cell: Aspirate the culture medium and wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) , sonicate to lyse the cells, and incubate on ice for 30 minutes.
    3. Suspension cell: Transfer the culture medium to a pre-cooled centrifuge tube. Centrifuge and aspirate the supernatant. Wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) , sonicate to lyse the cells, and incubate on ice for 30 minutes.
    4. Place the lysate into a pre-cooled microcentrifuge tube. Centrifuge at 4°C for 15 min. Collect the supernatant;
    5. Remove a small volume of lysate to determine the protein concentration;
    6. Combine the lysate with protein loading buffer. Boil 20 µL sample under 95-100°C for 5 min. Centrifuge for 5 min after cool down on ice.
     
    Electrophoretic separation
    1. According to the concentration of extracted protein, load appropriate amount of protein sample and marker onto SDS-PAGE gels for electrophoresis. Recommended separating gel (lower gel) concentration: 10%. Reference Table for Selecting SDS-PAGE Separation Gel Concentrations
    2. Power up 80V for 30 minutes. Then the power supply is adjusted (110 V~150 V), the Marker is observed, and the electrophoresis can be stopped when the indicator band of the predyed protein Marker where the protein is located is properly separated. (Note that the current should not be too large when electrophoresis, too large current (more than 150 mA) will cause the temperature to rise, affecting the result of running glue. If high currents cannot be avoided, an ice bath can be used to cool the bath.)
     
    Transfer membrane
    1. Take out the converter, soak the clip and consumables in the pre-cooled converter;
    2. Activate PVDF membrane with methanol for 1 min and rinse with transfer buffer;
    3. Install it in the order of "black edge of clip - sponge - filter paper - filter paper - glue -PVDF membrane - filter paper - filter paper - sponge - white edge of clip";
    4. The protein was electrotransferred to PVDF membrane. ( 0.45 µm PVDF membrane is recommended ) Reference Table for Selecting PVDF Membrane Pore Size Specifications
    Recommended conditions for wet transfer: 200 mA, 120 min.
    ( Note that the transfer conditions can be adjusted according to the protein size. For high-molecular-weight proteins, a higher current and longer transfer time are recommended. However, ensure that the transfer tank remains at a low temperature to prevent gel melting.)
     
    Block
    1. After electrotransfer, wash the film with TBST at room temperature for 5 minutes;
    2. Incubate the film in the blocking solution for 1 hour at room temperature;
    3. Wash the film with TBST for 3 times, 5 minutes each time.
     
    Antibody incubation
    1. Use primary antibody dilution buffer to prepare the primary antibody working liquid (recommended dilution ratio for primary antibody 1:200000), gently shake and incubate with the film at 4°C overnight;
    2. Wash the film with TBST 3 times, 5 minutes each time;
    3. Add the secondary antibody to the blocking solution and incubate with the film gently at room temperature for 1 hour;
    4. After incubation, wash the film with TBST 3 times for 5 minutes each time.
     
    Antibody staining
    1. Add the prepared ECL luminescent substrate (or select other color developing substrate according to the second antibody) and mix evenly;
    2. Incubate with the film for 1 minute, remove excess substrate (keep the film moist), wrap with plastic film, and expose in the imaging system.
    IHC
    Experimental Protocol:
     
    Deparaffinization/Rehydration
    1. Deparaffinize/hydrate sections:
    2. Incubate sections in three washes of xylene for 5 min each.
    3. Incubate sections in two washes of 100% ethanol for 10 min each.
    4. Incubate sections in two washes of 95% ethanol for 10 min each.
    5. Wash sections two times in dH2O for 5 min each.
    6.Antigen retrieval: For Citrate: Heat slides in a microwave submersed in 1X citrate unmasking solution until boiling is initiated; continue with 10 min at a sub-boiling temperature (95°-98°C). Cool slides on bench top for 30 min.
     
    Staining
    1. Wash sections in dH2O three times for 5 min each.
    2. Incubate sections in 3% hydrogen peroxide for 10 min.
    3. Wash sections in dH2O two times for 5 min each.
    4. Wash sections in wash buffer for 5 min.
    5. Block each section with 100–400 µl of blocking solution for 1 hr at room temperature.
    6. Remove blocking solution and add 100–400 µl primary antibody diluent in to each section. Incubate overnight at 4°C.
    7. Remove antibody solution and wash sections with wash buffer three times for 5 min each.
    8. Cover section with 1–3 drops HRPas needed. Incubate in a humidified chamber for 30 min at room temperature.
    9. Wash sections three times with wash buffer for 5 min each.
    10. Add DAB Chromogen Concentrate to DAB Diluent and mix well before use.
    11. Apply 100–400 µl DAB to each section and monitor closely. 1–10 min generally provides an acceptable staining intensity.
    12. Immerse slides in dH2O.
    13. If desired, counterstain sections with hematoxylin.
    14. Wash sections in dH2O two times for 5 min each.
    15. Dehydrate sections: Incubate sections in 95% ethanol two times for 10 sec each; Repeat in 100% ethanol, incubating sections two times for 10 sec each; Repeat in xylene, incubating sections two times for 10 sec each.
    16. Mount sections with coverslips and mounting medium.
     
    IP
    Experimental Procedure:
     
    Reagents and Preparation
    1. Basic buffers: 1× PBS or 1× TBS (pre-chilled on ice); 1× cell lysis buffer (add 1 mM PMSF protease inhibitor immediately before use; add phosphatase inhibitors for phosphoproteins).
    2. Capture medium: Protein A/G magnetic beads or agarose beads (Sepharose beads).
    3. Controls: Use an isotype control IgG matching the host species and IgG subclass of the primary antibody, at the same concentration. It is recommended to reserve a portion of the cell lysate that has not been subjected to immunoprecipitation as the Input control; if necessary, a beads-only control (beads added without antibody) may also be included.
    4. Loading and elution reagents: 3× or 4× SDS sample loading buffer (containing DTT/reducing agent); if non-denaturing elution is to be performed, prepare the corresponding elution buffer and neutralization buffer separately; for denaturing elution, 1× PBS is typically used to dilute the 3× or 4× SDS sample loading buffer to 1×.
     
    Cell Lysis and Sample Preparation (Native Protein Extraction)
    1. Cell harvesting: Discard the culture medium and wash the cells once with ice-cold 1× PBS.
    2. Cell lysis: Add 0.5–1 mL of ice-cold 1× cell lysis buffer to a 10-cm culture dish and incubate on ice for 5–10 minutes.
    3. Lysate collection and clarification: Scrape the cells and transfer the lysate to a microcentrifuge tube. Some adherent cells may require detachment using digestive enzymes or mechanical methods. Centrifuge at 14,000 rpm at 4°C for 5–15 min. Collect the supernatant as the clarified cell lysate. It is recommended to determine the protein concentration.
     
    Pre-clearing and Immunoprecipitation Reaction
    1. Pre-clearing of the lysate (recommended): Take an appropriate amount of beads (magnetic beads or agarose beads) and pre-wash 2–3 times with cell lysis buffer or 1× TBS/PBS. After pre-washing, it is recommended to remove the wash buffer as completely as possible before adding subsequent reagents, to avoid extra dilution of the sample. For lysis systems containing detergents or specific salt concentrations, prefer pre-washing with a buffer identical or compatible with the lysis buffer to minimize buffer-system mismatches.
    2. Pre-clearing treatment: Mix the cell lysate with the pre-washed beads and incubate with rotation at room temperature for 30–60 min, or at 4°C with rotation for 1–2 h.
    When using agarose beads, pellet the beads by centrifugation after incubation and collect the supernatant.
    When using magnetic beads, separate the beads using a magnetic stand after incubation and collect the supernatant.
    This step removes proteins that bind non-specifically to the beads. For unstable proteins, phosphoproteins, or protein complexes, incubation at 4°C is preferred to minimize protein degradation, dephosphorylation, or complex dissociation. Beads used for pre-clearing should generally not be pre-coupled with a specific antibody, to avoid loss of the target antigen.
    3. Formation of the “bead–antibody–antigen” immunocomplex
    Either of the following two approaches may be used:
    3.1 Pre-form the antibody–antigen complex, then add the beads: Add an appropriate amount of primary antibody to the pre-cleared supernatant obtained in step 2, and set up an isotype control IgG group in parallel. Incubate with rotation at 4°C overnight (recommended), or at room temperature with rotation for 2 h, to allow formation of the antibody–antigen complex.
    In parallel, take an appropriate amount of beads and pre-wash them as described in step 1 of this section. Add the antibody–antigen complex to the pre-washed magnetic or agarose beads and incubate with rotation at room temperature for 30 min–1 h, or at 4°C with rotation for 1–2 h, to allow the antibody–antigen complex to bind efficiently to the beads.
    3.2 Pre-form the bead–antibody complex, then add the cell lysate: Dilute the primary antibody in cell lysis buffer at the dilution ratio recommended in the antibody instruction manual to prepare the antibody working solution. Add an appropriate amount of pre-washed magnetic beads to the antibody working solution and incubate with rotation at room temperature for 15 min, or at 4°C with rotation for 1 h, to form the bead–antibody complex.
    Recover the beads by magnetic separation or centrifugation, discard the supernatant, and pre-wash the beads 2–3 times with 1× TBS. Then add the cell lysate and incubate with rotation at 4°C overnight (recommended), or at room temperature with rotation for 2 h.
     
    Washing of the Precipitate and Sample Elution
    1. Once immunoprecipitation is complete, separate the beads according to their type and discard the supernatant.
    Magnetic beads are separated using a magnetic stand.
    For agarose beads, low-speed centrifugation (500–1000 rpm) appropriate for the bead specifications should be used, to avoid bead compaction or damage caused by high-speed centrifugation.
    2. Washing the beads: Gently wash the beads 3–5 times with ice-cold 1× cell lysis buffer or 1× TBS/TBST. Keep the temperature low throughout the washes. After each addition of wash buffer, mix gently to fully resuspend the beads; then separate the beads using a magnetic stand or appropriate centrifugation, depending on the bead type, and remove the wash buffer thoroughly to minimize unbound and non-specifically bound components. During each wash, remove as much supernatant as possible while avoiding aspiration of the beads. After the final wash, remove residual wash buffer as completely as possible to prevent dilution of the eluate or interference with downstream analyses. Keep the samples on ice after each wash.
    3. Sample elution (choose one of the following):
    3.1 Denaturing direct elution (most commonly used): Add SDS sample loading buffer to the bead pellet to a final concentration of 1×. If 3× or 4× SDS sample loading buffer is used, it must first be diluted to 1×. Mix well and heat at 95–100°C for 5 minutes. Separate the beads and collect the supernatant for subsequent electrophoresis.
    3.2 Chemical / non-denaturing elution (preserves protein activity): After the final wash, separate the beads using a magnetic stand or low-speed centrifugation, depending on the bead type, and remove residual wash buffer as completely as possible to prevent dilution of the eluate. Add an appropriate amount of acidic elution buffer / high-salt elution buffer to the beads and resuspend them thoroughly. Mix gently and incubate briefly at room temperature to allow the immunocomplex to dissociate from the beads. Separate the beads with a magnetic stand or low-speed centrifugation, and transfer the eluate to a collection tube pre-filled with an appropriate amount of neutralization buffer; adjust the pH if necessary. To improve recovery, elution may be repeated and the eluates pooled. The composition and volume of the elution buffer and neutralization buffer should be determined according to the instructions for the beads and kit used.
    3.3 Post-elution sample handling
    For protein activity assays, native protein complex analysis, or other non-denaturing analyses: do not add SDS sample loading buffer; keep the sample on ice and proceed to the subsequent experiment as quickly as possible.
    For SDS-PAGE or Western blot: add SDS sample loading buffer to the neutralized or desalted eluate to a final concentration of 1×, and then process the sample according to the subsequent electrophoresis requirements.
    Select appropriate storage conditions according to the stability of the target protein and the requirements of downstream experiments, and avoid repeated freeze–thaw cycles.
     
    Downstream Analysis
    Western blot analysis: Take the supernatant and perform SDS-PAGE electrophoresis followed by membrane transfer. It is recommended to use light- and heavy-chain-specific or conformation-specific secondary antibodies to avoid interference of the immunoglobulin heavy/light chain bands (50 kDa / 25 kDa) with detection of the target protein. It is recommended to include Input, isotype control IgG-IP, and target antibody-IP samples on the same Western blot; if necessary, a beads-only control may also be added to evaluate immunoprecipitation efficiency and non-specific binding. Kinase activity assay (if applicable): skip the denaturation step, wash the beads with kinase buffer, then add substrate and ATP directly to perform the kinase reaction.
     

    Note: All lysis and immunoprecipitation procedures should be performed at 4°C or on ice to preserve the native conformation of proteins as much as possible and prevent their degradation.

    Datasheet & SDS

    生物学的記述

    Specificity
    HMGCS1 Antibody (Rabbit mAb) [D13C18] detects endogenous levels of total HMGCS1 protein.
    タンパク質の局在
    細胞質
    Uniprot ID
    Q01581
    Clone
    D13C18
    Synonym(s)
    HMGCS | HMGCS1 | HMG-CoA synthase | 3-hydroxy-3-methylglutaryl coenzyme A synthase
    Background
    3-Hydroxy-3-methylglutaryl-CoA synthase 1 (HMGCS1) is the cytosolic isoform of HMG-CoA synthase and acts as the first committed enzyme of the mevalonate branch of cholesterol biosynthesis, catalyzing the condensation of acetyl-CoA with acetoacetyl-CoA to generate HMG-CoA that feeds directly into HMG-CoA reductase and the downstream production of sterols and non‑sterol isoprenoids. The enzyme belongs to the thiolase superfamily and functions as a homodimeric cytosolic protein with a catalytic site that positions acetyl-CoA and acetoacetyl-CoA for Claisen condensation, providing a gatekeeping step that determines the flux of acetyl units from central carbon metabolism into the mevalonate pathway. HMGCS1 activity links acetyl-CoA availability to the synthesis of mevalonate-derived products such as cholesterol, dolichols, ubiquinone, and prenyl donors, and thereby influences membrane biogenesis, protein prenylation, and other lipid‑dependent processes that support cell growth and survival. Expression of HMGCS1 is detectable in many tissues and aligns with sites of active cholesterol synthesis, and transcriptional control integrates with sterol regulatory networks that coordinate HMGCS1 with HMG-CoA reductase and other mevalonate enzymes to maintain intracellular sterol homeostasis. Elevated HMGCS1 expression is a recurrent feature of tumor cells with heightened mevalonate pathway activity, where increased HMGCS1 levels correlate with aggressive phenotypes and provide a metabolic signature of cancer stem cell–enriched subpopulations in luminal and basal breast cancer models, associating this enzyme with self‑renewal capacity and resistance‑related traits. Functional targeting of HMGCS1 in these breast cancer models diminishes cancer stem cell markers, sphere‑forming capacity, and tumorigenic features more strongly than standard statin treatment and acts at the level of HMG-CoA generation upstream of HMG-CoA reductase. In gastric cancer, HMGCS1 expression aligns with tumor progression, and pathway analyses place this enzyme as a regulatory node whose activity supports proliferation, migration, and other malignant properties through sustained provision of mevalonate intermediates required for oncogenic signaling and membrane dynamics.
    References

    技術サポート

    ストックの作り方、阻害剤の保管方法、細胞実験や動物実験の際に注意すべき点など、製品を取扱う時に問い合わせが多かった質問に対しては取扱説明書でお答えしています。

    Handling Instructions

    他に質問がある場合は、お気軽にお問い合わせください。

    * 必須

    大学・企業名を記入してください
    名前を記入してください
    電子メール・アドレスを記入してください 有効なメールアドレスを入力してください
    お問い合わせ内容をご入力ください